Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: obtain (280), request (403)

Deceiving patients

Description: Can deception ever be justified?
Url: /HealthProfessionals/Clinical-law-updates/Deceiving-patients.aspx

Is there a role for next of kin?

Description: Whether admission to our hospital is recorded on paper or electronically, we faithfully record the patient's 'next of kin'. Is this
Url: /HealthProfessionals/Clinical-law-updates/Is-there-a-role-for-next-of-kin.aspx

Support for defending liberty

Description: Mr CP was a 91 year old man living alone. He had early dementia, but coped at home with assistance.
Url: /HealthProfessionals/Clinical-law-updates/Supportfordefendingliberty.aspx

Remuneration & Appointment Committee ToR March 2026

Description: Remuneration and Appointment Committee Terms of Reference Date Issued: 10 March 2026 Review Date: March 2027 Document Type:
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2026-Trust-documents/Remuneration-Appointment-Committee-ToR-March-2026.pdf

Belantamab Bortezomib Dexamethasone Weekly

Description: Chemotherapy Protocol BELANTAMAB MAFODOTIN – BORTEZOMIB - DEXAMETHASONE This protocol may require funding Regimen • Belantamab Mafodotin – Bortezomib -
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Belantamab-Bortezomib-Dexamethasone-Weekly-Ver1.pdf

Remuneration and Appointment Committee ToR March 2025

Description: Remuneration and Appointment Committee Terms of Reference Date Issued: 11 March 2025 Review Date: March 2026 Document Type:
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Remuneration-and-Appointment-Committee-ToR-March-2025.pdf

Bevacizumab (15mgkg), Carboplatin and Gemcitabine (1,8)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC4)-GEMCITABINE (day 1, 8) Regimen • Ovary-B
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkgCarboplatinAUC4Gemcitabineday18.pdf

Remuneration and Appointment Committee ToR Feb 2023

Description: Remuneration and Appointment Committee Terms of Reference Date Issued: 28 February 2023 Review Date: February 2024 Document
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2023-Trust-documents/Remuneration-and-Appointment-Committee-ToR-Feb-2023.pdf

Remuneration and Appointment Committee ToR May 2022

Description: Remuneration and Appointment Committee Terms of Reference Date Issued: 26 May 2022 Review Date: November 2022 Document Type:
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Remuneration-and-Appointment-Committee-ToR-May-2022.pdf

MyelomaVTDBortezomib(SC)DexamethasoneThalidomideVer1

Description: Chemotherapy Protocol MULTIPLE MYELOMA VTD (SC-28)-BORTEZOMIB (SC)-DEXAMETHASONE-THALIDOMIDE (28 day) Regimen Multiple Myeloma – VTD (28)-Bortezomib (SC)-Dexamethasone
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaVTDBortezomibSCDexamethasoneThalidomideVer1.pdf

91 to 100 of 565

Previous … 8 9 10 11 12 … Next